SCHEMBL7138367

SCHEMBL7138367

COCCOc1cc(NC(=O)OC(C)(C)C)c(NC(=O)CC(=O)c2cccc(I)c2)cc1C#Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.39
VCP P55072 1/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
AHR P35869 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MDH1 P40925 1/20 0.34
MDH2 P40926 1/20 0.34
DRD2 P14416 2/20 0.33
DRD4 P21917 2/20 0.33
DRD3 P35462 2/20 0.33
SLC16A3 O15427 1/20 0.33
PTGES O14684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7141229 0.91 HTT (0.37) HTTVCPKMT2AMEN1ALDH1A1
SCHEMBL7701365 0.90 HTT (0.40) HTTVCPKMT2AMEN1ALDH1A1
SCHEMBL7146923 0.89 SLC16A3 (0.36) HTTVCPKMT2AMEN1ALDH1A1
SCHEMBL7140018 0.84 KIT (0.37) HTTVCPALDH1A1L3MBTL1MAPT
SCHEMBL5868952 0.83 MEN1 (0.39) KMT2AMEN1ALDH1A1PTGES
SCHEMBL7142827 0.83 KMT2A (0.43) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL7706579 0.82 PTGDR2 (0.42)
SCHEMBL7149260 0.82 RORC (0.37) KMT2AMEN1PTGES
SCHEMBL7142666 0.82 PTGDR2 (0.36) KMT2AMEN1PTGES
SCHEMBL7142218 0.79 VCP (0.40) HTTVCPKMT2AKDM4ESLC16A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed